Status:
COMPLETED
Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy
Lead Sponsor:
Aurolab
Collaborating Sponsors:
Raja Ramanna Centre for Advanced Technology (RRCAT)
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To Demonstrate that indigenous green laser produces similar treatment effect on the retina when compared with already available green laser.
Detailed Description
Proliferative Diabetic Retinopathy is ocular pathology in poor glycaemic controlled Diabetic patient Characterized by micro-vascular pathology with capillary closure in the retina leading to hypoxia o...
Eligibility Criteria
Inclusion
- Patients more than 18 years of age
- Eyes with proliferative diabetic retinopathy requiring laser photocoagulation
Exclusion
- Eyes with media opacities not allowing proper fundus photography or adequate laser photocoagulation
- Patients requiring more than two sessions of laser photocoagulation
- Patients who had undergone previous laser photocoagulation
- Patients who had undergone any previous vitreo-retinal surgery
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00355680
Start Date
December 1 2005
End Date
July 1 2006
Last Update
February 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arvind Eye Hospital
Madurai, Tamil Nadu, India, 625 020